Financial Toxicity in Patients With Early-stage Breast Cancer
Assessing Prevalence of Financial Burden and Impact of Cancer on Financial toxicIty in Patients With Early-stage Breast Cancer
National Cancer Institute, Naples
864 participants
Sep 30, 2025
OBSERVATIONAL
Conditions
Summary
Non-profit, multicenter, prospective, observational study. This study aims to evaluate whether the articulated treatment algorithm that is now possible for early-stage breast cancer patients does produce tangible changes of financial distress over the time and whether the determinants of financial distress change their relative weight over the time.
Eligibility
Inclusion Criteria3
- Signed informed consent form
- Age \> 18 years at the time of study entry
- Histologically confirmed stage I-III invasive breast carcinoma before starting any systemic treatment.
Exclusion Criteria3
- Stage IV invasive breast carcinoma
- Major cognitive dysfunction or psychiatric disorders
- Any previous systemic treatment for the current breast cancer
Interventions
The PROFFIT questionnaire is a PRO instrument composed by 16 items encompassing all the major life domains where FT can be expressed and is formed by two type of items: (1) outcome (items 1-7) and (2) determinants (items 8-16). EORTC QLQ-C30, EORTC QLQ-BR42 and HADS questionnaires are currently used in clinical practice
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07354165